Boston, MA -- (SBWIRE) -- 09/10/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (WebMD Health Corp. (NASDAQ:WBMD), Comstock Resources Inc (NYSE:CRK), TriQuint Semiconductor (NASDAQ:TQNT), Affymetrix, Inc.(NASDAQ:AFFX)
WebMD Health Corp. (NASDAQ:WBMD) shares gained 0.09% to $33.12. The company on August 12 announced that its Board of Directors has appointed David J. Schlanger as Chief Executive Officer of WebMD and Steven L. Zatz, M.D. as its President. Mr. Schlanger has served as Interim CEO since May 2013 and in other senior roles at WebMD and its predecessor companies for more than ten years prior to that time. Dr. Zatz has been with WebMD and its predecessor companies for more than ten years, most recently as Executive Vice President, Professional Services of WebMD, where he was responsible for the Company's professional websites and services including its flagship site for healthcare professionals, Medscape.com.
How Should Investors Trade WBMD After The Recent Volatility? Get Free Report Here
Comstock Resources Inc (NYSE:CRK) shares jumped 4.16% to $15.27. The company will begin trading ex-dividend on September 04, 2013. A cash dividend payment of $0.125 per share is scheduled to be paid on September 16, 2013. Shareholders who purchased CRK stock prior to the ex-dividend date are eligible for the cash dividend payment. At the current stock price of $14.6, the dividend yield is 3.42%.
How Should Investors Trade CRK After The Recent Volatility? Get Free Report Here
TriQuint Semiconductor (NASDAQ:TQNT) shares jumped 0.88% to $8. Raymond James downgraded shares of TQNT from a market perform rating to an underperform rating in a report issued on August 26. Separately, Analysts at Zacks upgraded shares of TriQuint Semiconductor from a neutral rating to an outperform rating in a research note to investors on Tuesday, July 30th. They now have a $9.50 price target on the stock.
Is TQNT A Good Buy After The Recent Price Movement? Find Out Here
Affymetrix, Inc.(NASDAQ:AFFX) shares increased 5.35% to $6.30. The company on August 5 announced the launch of the new OncoScan? FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor samples, at the Cancer Cytogenomics Microarray Consortium conference being held in Chicago.
Additionally, the company on July 31 reported its operating results for the second quarter of 2013. Product revenue for the second quarter of 2013 was $74.2 million and service and other revenue was $5.3 million. For the second quarter of 2013, operating expenses were $45.1 million on a GAAP basis as compared to $54.1 million in 2012.
Is AFFX A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)